Amyloid precursor protein carboxy-terminal fragments modulate G-proteins and adenylate cyclase activity in Alzheimer's disease brain

Brain Res Mol Brain Res. 2003 Sep 10;117(1):73-82. doi: 10.1016/s0169-328x(03)00292-4.

Abstract

The influence of three C-terminal sequences and of transmembrane domain from amyloid precursor protein (APP) on the activity of G-proteins and of the coupled cAMP-signalling system in the postmortem Alzheimer's disease (AD) and age-matched control brains was compared. 10 microM APP(639-648)-APP(657-676) (PEP1) causes a fivefold stimulation in the [35S]GTPgammaS-binding to control hippocampal G-proteins. APP(657-676) (PEP2) and APP(639-648) (PEP4) showed less pronounced stimulation whereas cytosolic APP(649-669) (PEP3) showed no regulatory activity in the [35S]GTPgammaS-binding. PEP1 also showed 1.4-fold stimulatory effect of on the high-affinity GTPase and adenylate cyclase activity in control membranes, whereas in AD hippocampal membranes the stimulatory effect of PEP1 was substantially weaker. The PEP1 stimulation of the [35S]GTPgammaS-binding to the control membranes was significantly reduced by 1.5 mM glutathione, 0.5 mM antioxidant N-acetylcysteine and, in the greatest extent, by 0.01 mM of desferrioxamine. In AD hippocampus these antioxidants revealed no remarkable reducing effect on PEP1-induced stimulation. Our results suggest that C-terminal and transmembrane APP sequences possess receptor-like G-protein activating function in human hippocampus and that abnormalities of this function contribute to AD progression. The stimulatory action of these sequences on G-protein mediated signalling suggests the region-specific formation of reactive species.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / administration & dosage
  • Adenylyl Cyclases / metabolism*
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / enzymology*
  • Alzheimer Disease / metabolism
  • Amyloid beta-Protein Precursor / metabolism*
  • Binding Sites
  • Case-Control Studies
  • Cell Membrane / drug effects
  • Cell Membrane / enzymology
  • Deferoxamine / administration & dosage
  • Dose-Response Relationship, Drug
  • Female
  • Free Radical Scavengers / pharmacology
  • Frontal Lobe / drug effects
  • Frontal Lobe / enzymology
  • GTP Phosphohydrolases / analysis
  • GTP-Binding Proteins / metabolism*
  • Glutathione / administration & dosage
  • Guanosine 5'-O-(3-Thiotriphosphate) / metabolism
  • Hippocampus / cytology
  • Hippocampus / drug effects
  • Hippocampus / enzymology*
  • Humans
  • Hydrogen Peroxide / administration & dosage
  • Iron Chelating Agents
  • Oxidants
  • Peptide Fragments / chemistry
  • Peptide Fragments / classification
  • Peptide Fragments / metabolism
  • Peptide Fragments / pharmacology
  • Sulfur Isotopes

Substances

  • Amyloid beta-Protein Precursor
  • Free Radical Scavengers
  • Iron Chelating Agents
  • Oxidants
  • Peptide Fragments
  • Sulfur Isotopes
  • Guanosine 5'-O-(3-Thiotriphosphate)
  • Hydrogen Peroxide
  • GTP Phosphohydrolases
  • GTP-Binding Proteins
  • Adenylyl Cyclases
  • Glutathione
  • Deferoxamine
  • Acetylcysteine